http://www.acc.org/Feed?clinicalTopicID=8e0665e1-fe1f-4915-88f0-f894baeef01f Clinical Topic Feed: Pulmonary Hypertension en /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-4pm-surviv-acc-2026 Among patients with a failed mitral bioprosthetic valve, transcatheter mitral valve-in-valve (mVIV) treatment was associated with a lower rate of death or disabling stroke at one year compared with standard repeat mitral valve replacement surgery (rMVR), according to results from the SURVIV study presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans. 1774818000000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-1045am-cadence-acc-2026 Sotatercept, an activin signaling inhibitor, was associated with significant improvements in blood pressure and vascular health in patients with heart failure with preserved ejection fraction (HFpEF) and severe combined post and precapillary pulmonary hypertension (CpcPH), according to results of the CADENCE study presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans and simultaneously published in Circulation. 1774800360000 Articles and Stories /Latest-in-Cardiology/Articles/2026/01/28/14/24/eagles-eye-view-28jan2025 In this week’s View, Dr. Eagle looks at exercise systolic blood pressure (SBP) during stress testing related to cardiovascular (CV) events. 1769610360000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/01/20/18/24/Molecular-Imaging-Biomarker Uptake of fluorine-18-fibroblast activation protein inhibitor (18F-FAPI) in the right ventricular (RV) free wall, as captured by PET/CT, is a promising, noninvasive indicator for pulmonary arterial hypertension (PAH), according to new research published Jan. 8 in JACC: Cardiovascular Imaging. 1768998600000 Articles and Stories /Latest-in-Cardiology/Articles/2025/12/18/16/40/New-ACC-AHA-Guideline-Addresses-Management-of-Congenital-Heart-Disease-in-Adults The ACC and AHA, in collaboration with several leading medical societies, have released a new clinical guideline focused on the management of adults with congenital heart disease (ACHD). The guideline provides updated recommendations for monitoring, counseling and treating ACHD and replaces previous guidance released in 2018. 1766084940000 Articles and Stories /Latest-in-Cardiology/Articles/2025/11/01/01/Editors-Corner-Pulmonary-Hypertension Our cover story this month takes on the daunting task of describing the complexities of pulmonary hypertension (PH). The story emphasizes that patients with PH need early recognition and treatment. 1761999600000 Articles and Stories /Latest-in-Cardiology/Articles/2025/11/01/01/Cover-Story-Pulmonary-Hypertension Despite affecting approximately 1% of the population and carrying significant mortality risk, pulmonary hypertension (PH) remains underrecognized compared to other cardiovascular conditions. Several interconnected factors contribute to this clinical blind spot. 1761999540000 Articles and Stories /Latest-in-Cardiology/Articles/2025/11/01/01/From-the-Member-Sections-Shunt-Related-Pulmonary-Hypertension Pregnancies complicated by pulmonary hypertension (PH) are uncommon, however, they are associated with significant morbidity and mortality. Notably, 64% of pregnancies complicated by PH occur in women with underlying congenital heart disease (CHD). 1761999240000 Articles and Stories /Education-and-Meetings/Patient-Case-Quizzes/2025/10/16/13/42/ACHD-With-ASD A 30-year-old woman presents to the cardiology clinic with dyspnea on exertion. In the last 6 months, she has noticed shortness of breath with exertion during high-intensity exercise classes, which she could previously complete without limitations. She has no significant medical history. 1760637000000 Educational Activities /Latest-in-Cardiology/Articles/2025/10/15/13/18/eagles-eye-view-15oct2025 In this week’s View, Dr. Eagle looks at the potential value of sodium-glucose cotransporter 2 (SGLT2) agents after transcatheter aortic valve implantation (TAVI). 1760534400000 Articles and Stories